Michael D. Liang

798 total citations
10 papers, 667 citations indexed

About

Michael D. Liang is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Michael D. Liang has authored 10 papers receiving a total of 667 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Immunology. Recurrent topics in Michael D. Liang's work include Cancer therapeutics and mechanisms (5 papers), Neutropenia and Cancer Infections (5 papers) and Immune Response and Inflammation (4 papers). Michael D. Liang is often cited by papers focused on Cancer therapeutics and mechanisms (5 papers), Neutropenia and Cancer Infections (5 papers) and Immune Response and Inflammation (4 papers). Michael D. Liang collaborates with scholars based in United States, Ukraine and Malaysia. Michael D. Liang's co-authors include Matthew J. Fenton, Sylvia Marecki, Stefanie N. Vogel, Kurt A. Heldwein, Chris H. Takimoto, Jean L. Grem, Natalia Cuesta, Karen E. Thomas, Aileen M. Marty and Carmen J. Allegra and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Michael D. Liang

10 papers receiving 658 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael D. Liang United States 9 292 268 261 87 76 10 667
Katharina A. Remer Germany 14 258 0.9× 156 0.6× 225 0.9× 86 1.0× 61 0.8× 17 733
Eiji Shinya Japan 16 455 1.6× 290 1.1× 203 0.8× 72 0.8× 58 0.8× 24 808
M. Cardinali United States 15 186 0.6× 204 0.8× 323 1.2× 124 1.4× 83 1.1× 25 783
Ka Yee Fung Australia 14 434 1.5× 219 0.8× 218 0.8× 105 1.2× 80 1.1× 19 741
Neil C. Robson Australia 17 530 1.8× 158 0.6× 336 1.3× 104 1.2× 80 1.1× 20 801
Jean‐Pierre Mach Switzerland 14 252 0.9× 130 0.5× 264 1.0× 50 0.6× 42 0.6× 26 772
Marialuisa Barbagallo Italy 13 547 1.9× 270 1.0× 258 1.0× 60 0.7× 72 0.9× 20 865
Anthony J. Infante United States 16 408 1.4× 117 0.4× 178 0.7× 118 1.4× 83 1.1× 39 818
Cynthia Pérez United States 14 325 1.1× 308 1.1× 206 0.8× 145 1.7× 69 0.9× 30 800
C. A. Savary United States 17 623 2.1× 196 0.7× 109 0.4× 93 1.1× 86 1.1× 33 863

Countries citing papers authored by Michael D. Liang

Since Specialization
Citations

This map shows the geographic impact of Michael D. Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Liang more than expected).

Fields of papers citing papers by Michael D. Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael D. Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Liang. The network helps show where Michael D. Liang may publish in the future.

Co-authorship network of co-authors of Michael D. Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Michael D. Liang. A scholar is included among the top collaborators of Michael D. Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael D. Liang. Michael D. Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Liang, Michael D., Yue Zhang, Daniel C. McDevit, Sylvia Marecki, & Barbara S. Nikolajczyk. (2006). The Interleukin-1β Gene Is Transcribed from a Poised Promoter Architecture in Monocytes. Journal of Biological Chemistry. 281(14). 9227–9237. 48 indexed citations
2.
Liang, Michael D., Aranya Bagchi, H. Shaw Warren, et al.. (2005). Bacterial Peptidoglycan‐Associated Lipoprotein: A Naturally Occurring Toll‐Like Receptor 2 Agonist That Is Shed into Serum and Has Synergy with Lipopolysaccharide. The Journal of Infectious Diseases. 191(6). 939–948. 86 indexed citations
3.
Quinn, Mary, et al.. (2003). A phase I study of 9-aminocamptothecin as a colloidal dispersion formulation given as a fortnightly 72-h infusion. Cancer Chemotherapy and Pharmacology. 52(4). 333–338. 8 indexed citations
4.
Heldwein, Kurt A., Michael D. Liang, Karen E. Thomas, et al.. (2003). TLR2 and TLR4 serve distinct roles in the host immune response against Mycobacterium bovis BCG. Journal of Leukocyte Biology. 74(2). 277–286. 179 indexed citations
5.
Marecki, Sylvia, et al.. (2001). PU.1 and Multiple IFN Regulatory Factor Proteins Synergize to Mediate Transcriptional Activation of the Human IL-1β Gene. The Journal of Immunology. 166(11). 6829–6838. 98 indexed citations
6.
Thomas, Rebecca R., William L. Dahut, Nancy Harold, et al.. (2001). A phase I and pharmacologic study of 9-aminocamptothecin administered as a 120-h infusion weekly to adult cancer patients. Cancer Chemotherapy and Pharmacology. 48(3). 215–222. 11 indexed citations
7.
Takimoto, Chris H., William L. Dahut, Mark T. Marino, et al.. (1997). Pharmacodynamics and pharmacokinetics of a 72-hour infusion of 9-aminocamptothecin in adult cancer patients.. Journal of Clinical Oncology. 15(4). 1492–1501. 39 indexed citations
8.
Dahut, William L., Nancy Harold, Chris H. Takimoto, et al.. (1996). Phase I and pharmacologic study of 9-aminocamptothecin given by 72-hour infusion in adult cancer patients.. Journal of Clinical Oncology. 14(4). 1236–1244. 61 indexed citations
9.
Takimoto, Chris H., Zhi Hong Lu, Ruiwen Zhang, et al.. (1996). Severe neurotoxicity following 5-fluorouracil-based chemotherapy in a patient with dihydropyrimidine dehydrogenase deficiency.. PubMed. 2(3). 477–81. 133 indexed citations
10.
Takimoto, Chris H., William L. Dahut, Nancy Harold, et al.. (1996). Clinical Pharmacology of 9‐Aminocamptothecin. Annals of the New York Academy of Sciences. 803(1). 324–326. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026